Grupo de Apoio ao Adolescente e à Criança com Câncer (GRAACC), Instituto de Oncologia Pediatrica (IOP), Sao Paulo Federal University (UNIFESP), Rua Pedro de Toledo 572-Vila Clementino, 04039-001 São Paulo, SP, Brazil.
Division of Infectious Diseases, Department of Medicine, Escola Paulista de Medicina, Sao Paulo Federal University (UNIFESP), Rua Pedro de Toledo 669, 10th Floor, 04039-001 São Paulo, SP, Brazil.
Mediators Inflamm. 2017;2017:8291316. doi: 10.1155/2017/8291316. Epub 2017 Jul 9.
The study aimed to describe the kinetics of various cytokines from day 1 to day 14 of the onset of fever in neutropenic children and to evaluate their performances as discriminators of sepsis in the first 24 hours of fever, the possible influence of filgrastim, and the functioning of the IL-23/IL-17 axis.
IL-1, TNF-, IL-10, IL-12/23p40, IL-21, IL-6, IL-8, IL-17, G-CSF, and GM-CSF were measured in plasma on days 1, 2, 3, 5, and 14 from the onset of fever in 35 patients.
Thirteen patients (37.1%) developed sepsis. In mixed models, IL-6, IL-8, IL-10, and G-CSF showed higher estimated means in septic patients ( < 0.005), and IL-12/23p40 and IL-17 in nonseptic patients ( < 0.05). On day 1, IL-6, IL-8, and IL-10 appeared upregulated in patients who received filgrastim. Only IL-6, IL-8, IL-10, and procalcitonin were useful as discriminators of sepsis. Associating the markers with each other or to a risk assessment model improved performance.
Cytokines kinetics showed proinflammatory and anti-inflammatory responses similar to what is described in nonneutropenic patients. IL-8, IL-6, IL-10, and procalcitonin are useful as early biomarkers of sepsis. Filgrastim upregulates expression of these markers, and we observed deficiency in the IL-23-IL-17 axis accompanying sepsis.
本研究旨在描述中性粒细胞减少症患儿发热第 1 天至第 14 天各种细胞因子的动力学,并评估它们在发热后 24 小时内作为脓毒症鉴别因子的性能,以及粒细胞集落刺激因子(filgrastim)的可能影响和 IL-23/IL-17 轴的功能。
在 35 例发热患者中,在发热第 1、2、3、5 和 14 天测量血浆中的 IL-1、TNF-α、IL-10、IL-12/23p40、IL-21、IL-6、IL-8、IL-17、G-CSF 和 GM-CSF。
13 例患者(37.1%)发生脓毒症。在混合模型中,IL-6、IL-8、IL-10 和 G-CSF 在脓毒症患者中的估计平均值较高(<0.005),而 IL-12/23p40 和 IL-17 在非脓毒症患者中较低(<0.05)。在第 1 天,接受 filgrastim 的患者中 IL-6、IL-8 和 IL-10 上调。只有 IL-6、IL-8、IL-10 和降钙素原可用作脓毒症的鉴别因子。将标志物相互关联或与风险评估模型关联可提高性能。
细胞因子动力学显示出与非中性粒细胞减少症患者相似的促炎和抗炎反应。IL-8、IL-6、IL-10 和降钙素原可用作脓毒症的早期生物标志物。filgrastim 上调这些标志物的表达,我们观察到伴随脓毒症的 IL-23-IL-17 轴缺陷。